OmniComm Systems (OTCMKTS:OMCM) versus Tabula Rasa HealthCare (OTCMKTS:TRHC) Financial Survey

Share on StockTwits

OmniComm Systems (OTCMKTS:OMCM) and Tabula Rasa HealthCare (NASDAQ:TRHC) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, dividends, earnings, valuation, institutional ownership, profitability and analyst recommendations.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for OmniComm Systems and Tabula Rasa HealthCare, as reported by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OmniComm Systems 0 0 0 0 N/A
Tabula Rasa HealthCare 0 2 7 1 2.90

Tabula Rasa HealthCare has a consensus price target of $84.23, indicating a potential upside of 73.60%. Given Tabula Rasa HealthCare’s higher probable upside, analysts plainly believe Tabula Rasa HealthCare is more favorable than OmniComm Systems.


This table compares OmniComm Systems and Tabula Rasa HealthCare’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
OmniComm Systems 7.18% -13.19% 18.74%
Tabula Rasa HealthCare -18.15% 4.22% 1.74%

Risk & Volatility

OmniComm Systems has a beta of 0.86, suggesting that its stock price is 14% less volatile than the S&P 500. Comparatively, Tabula Rasa HealthCare has a beta of 1.68, suggesting that its stock price is 68% more volatile than the S&P 500.

Earnings & Valuation

This table compares OmniComm Systems and Tabula Rasa HealthCare’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
OmniComm Systems $27.10 million 1.51 $3.69 million N/A N/A
Tabula Rasa HealthCare $204.27 million 5.22 -$47.27 million $0.34 142.71

OmniComm Systems has higher earnings, but lower revenue than Tabula Rasa HealthCare.

Insider & Institutional Ownership

86.7% of Tabula Rasa HealthCare shares are owned by institutional investors. 48.5% of OmniComm Systems shares are owned by company insiders. Comparatively, 14.0% of Tabula Rasa HealthCare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.


Tabula Rasa HealthCare beats OmniComm Systems on 8 of the 12 factors compared between the two stocks.

About OmniComm Systems

OmniComm Systems, Inc. operates as a healthcare technology company worldwide. The company engages in the provision of Web-based electronic data capture (EDC) and eClinical software and services for pharmaceutical and biotechnology companies, clinical research organizations (CROs), and other clinical trial sponsors. It offers TrialMaster, which allows organizations conducting clinical trials to collect and manage the data over the Internet; TrialOne Phase I Clinic Automation, a software application suite that provides clinical trial site sponsors, study investigators, and study monitors with various tools designed to make the overall Phase I clinic operation; and IRTMaster, which offers interactive response technology in support of the randomization process in clinical trials. The company also provides eClinical Suite that comprises a set of tools for collecting and managing clinical data, including EDC for real-time entry and double data entry (DDE) for entry from paper originals; and Promasys, a clinical trial data management system for DDE and EDC, which is primarily used at research institutions for investigator-initiated trials. In addition, it offers consulting and professional services, such as project management, clinical services, training, custom configuration, system integration, standard operating procedures and implementation assistance, installation, and validation services, as well as application hosting and support services. The company sells its products through its direct sales force and relationships with CRO partners, as well as through co-marketing agreements with vendor and channel partners. OmniComm Systems, Inc. was founded in 1996 and is headquartered in Fort Lauderdale, Florida.

About Tabula Rasa HealthCare

Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the field of medication safety in the United States. The company's proprietary Medication Risk Mitigation Matrix delivers a multi-drug review, which identifies medication-related risks. Its cloud-based software applications include EireneRx, a medication decision-support and e-prescribing platform to access patients' medication-related information; and MedWise that provides medication decision support components for clients seeking to manage their medication risk and improve medication outcomes, and patient relationships by enhancing their existing systems. The company's cloud-based software applications also comprise RxCompanion, a medication therapy management software platform for the identification and resolution of medication and other health related problems; TruChart, an electronic health record (EHR) system for Programs of All-Inclusive Care for the Elderly (PACE) programs; and PACElogic, which deliver real-time sharable workflows comprising EHR, customer relationship management, claims adjudication, electronic data interchange, care management, coordination, planning, integration with community-based providers, and various Federal and State required reporting for PACE organizations and small health plans. Tabula Rasa HealthCare, Inc. also offers clinical pharmacist collaboration, prescription fulfillment and reminder packaging, and pharmacy cost management services, as well as health plan management services, including risk adjustment and third party administrator services. As of December 31, 2018, it served 224 healthcare organizations. The company offers its cloud-based software solutions to prescribers, pharmacists, and healthcare organizations for managing the medication-related needs of their patients. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey.

Receive News & Ratings for OmniComm Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OmniComm Systems and related companies with's FREE daily email newsletter.